Institutional Ownership Stoke Therapeutics, Inc. (STOK)
This table provides information about the institutional ownership of Stoke Therapeutics, Inc. (STOK). We have compiled data on the 136 institutions that hold shares in the stock, with a total of 57.3 Million shares, which have been reported (via 13F filing form) to have a value of $458 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Skorpios Trust
|
Feb 05, 2025 Q4 2024 |
6,906,181
shares
|
$54.2 Million
99.8% of portfolio
|
Q4 2024
Reduced 22.46%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
5,409,169
shares
|
$42.5 Million
0.0% of portfolio
|
Q2 2024
Added 40.19%
|
|
|
Lynx1 Capital Management LP
San Juan, PR |
Feb 14, 2025 Q4 2024 |
5,187,191
shares
|
$40.7 Million
22.22% of portfolio
|
Q3 2024
New holding
|
|
|
Rtw Investments, LP
New York, NY |
Feb 14, 2025 Q4 2024 |
5,123,525
shares
|
$40.2 Million
0.92% of portfolio
|
Q4 2024
Added 10.13%
|
|
|
Baker Bros. Advisors LP
New York, NY |
Feb 14, 2025 Q4 2024 |
4,633,838
shares
|
$36.4 Million
0.57% of portfolio
|
Q4 2024
Added 6.08%
|
|
|
Redmile Group, LLC
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
4,593,629
shares
|
$36.1 Million
3.96% of portfolio
|
Q4 2024
Reduced 2.54%
|
|
|
Morgan Stanley
New York, NY |
Feb 14, 2025 Q4 2024 |
3,437,244
shares
|
$27 Million
0.0% of portfolio
|
Q4 2024
Reduced 18.26%
|
|
|
Toronto Dominion Bank
Toronto, Ontario, A6 |
Feb 19, 2025 Q4 2024 |
3,173,258
shares
|
$24.9 Million
0.06% of portfolio
|
Q4 2024
New holding
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Feb 11, 2025 Q4 2024 |
2,731,198
shares
|
$21.4 Million
0.0% of portfolio
|
Q4 2024
Reduced 1.02%
|
|
|
Siren, L.L.C.
New York, NY |
Feb 14, 2025 Q4 2024 |
2,000,000
shares
|
$15.7 Million
0.97% of portfolio
|
Q4 2024
New holding
|
|
|
State Street Corp
Boston, MA |
Feb 14, 2025 Q4 2024 |
1,587,663
shares
|
$12.5 Million
0.0% of portfolio
|
Q4 2024
Reduced 8.17%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Feb 11, 2025 Q4 2024 |
1,368,967
shares
|
$10.7 Million
0.0% of portfolio
|
Q4 2024
Reduced 1.78%
|
|
|
Assenagon Asset Management S.A.
|
Jan 14, 2025 Q4 2024 |
1,350,925
shares
|
$10.6 Million
0.03% of portfolio
|
Q4 2024
Added 2.93%
|
|
|
Marshall Wace, LLP
London, X0 |
Feb 13, 2025 Q4 2024 |
951,432
shares
|
$7.47 Million
0.01% of portfolio
|
Q4 2024
Reduced 43.05%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Feb 12, 2025 Q4 2024 |
877,095
shares
|
$6.89 Million
0.0% of portfolio
|
Q4 2024
Added 0.72%
|
|
|
Bio Impact Capital LLC
Cambridge, MA |
Feb 14, 2025 Q4 2024 |
685,826
shares
|
$5.38 Million
1.13% of portfolio
|
Q4 2024
Added 43.04%
|
|
|
Granahan Investment Management, LLC
Waltham, MA |
Feb 14, 2025 Q4 2024 |
567,689
shares
|
$4.46 Million
0.29% of portfolio
|
Q4 2024
Reduced 11.98%
|
|
|
Dimensional Fund Advisors LP
Austin, TX |
Feb 13, 2025 Q4 2024 |
538,900
shares
|
$4.23 Million
0.0% of portfolio
|
Q4 2024
Added 103.35%
|
|
|
Northern Trust Corp
Chicago, IL |
Feb 14, 2025 Q4 2024 |
350,788
shares
|
$2.75 Million
0.0% of portfolio
|
Q4 2024
Added 3.43%
|
|
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
Feb 14, 2025 Q4 2024 |
350,614
shares
|
$2.75 Million
0.0% of portfolio
|
Q4 2024
Reduced 24.19%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Feb 06, 2025 Q4 2024 |
342,129
shares
|
$2.69 Million
0.0% of portfolio
|
Q4 2024
Added 8.22%
|
|
|
Norges Bank
Oslo, Q8 |
Feb 12, 2025 Q4 2024 |
314,800
shares
|
$2.47 Million
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
Checkpoint Capital L.P.
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
305,387
shares
|
$2.4 Million
1.71% of portfolio
|
Q4 2024
Added 93.88%
|
|
|
Tang Capital Management LLC
San Diego, CA |
Feb 14, 2025 Q4 2024 |
300,000
shares
|
$2.36 Million
0.25% of portfolio
|
Q4 2024
New holding
|
|
|
Schonfeld Strategic Advisors LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
291,795
shares
|
$2.29 Million
0.02% of portfolio
|
Q4 2024
New holding
|